Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)
China flag China · Delayed Price · Currency is CNY
6.94
+0.08 (1.17%)
Feb 3, 2026, 3:04 PM CST

SHE:002198 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
409.24375.41533.03659.03574.28543.85
Other Revenue
0.760.760.20.170.440.88
410376.17533.23659.2574.71544.73
Revenue Growth (YoY)
-1.35%-29.45%-19.11%14.70%5.50%8.84%
Cost of Revenue
169.27151.91186.34229.22143.26148.08
Gross Profit
240.73224.25346.9429.98431.45396.65
Selling, General & Admin
175.79185.89292.82351.17379.1346.89
Research & Development
8.346.7610.115.3414.49.38
Other Operating Expenses
7.967.199.0710.5910.679.51
Operating Expenses
197.08203.88311.34379.76402.16366.85
Operating Income
43.6520.3735.5650.2229.2929.8
Interest Expense
-0-0-0-0.45-1.02-3.99
Interest & Investment Income
0.712.082.72.743.671.32
Earnings From Equity Investments
------3.64
Other Non Operating Income (Expenses)
-0.06-0.020.01-01.48-0.03
EBT Excluding Unusual Items
44.322.4438.2752.533.4223.46
Gain (Loss) on Sale of Investments
-0.24-0.530.26-28.8-
Gain (Loss) on Sale of Assets
-0.131.610.14-0.01-0.19-0.03
Asset Writedown
0.85----0.01-0.02
Other Unusual Items
1.251.050.44-1.651.39-0.39
Pretax Income
46.0325.139.3751.15.8223.02
Income Tax Expense
6.54.485.057.164.353.18
Net Income
39.5320.6134.3243.931.4819.84
Net Income to Common
39.5320.6134.3243.931.4819.84
Net Income Growth
221.73%-39.94%-21.88%2874.04%-92.55%-
Shares Outstanding (Basic)
511508508507509507
Shares Outstanding (Diluted)
511508508507509507
Shares Change (YoY)
1.05%-0.00%0.07%-0.41%0.40%-0.01%
EPS (Basic)
0.080.040.070.090.000.04
EPS (Diluted)
0.080.040.070.090.000.04
EPS Growth
218.40%-39.94%-21.94%2886.21%-92.58%-
Free Cash Flow
-79.8722.1493.3924.4149.4685.19
Free Cash Flow Per Share
-0.160.040.180.050.100.17
Dividend Per Share
--0.050---
Gross Margin
58.71%59.61%65.05%65.23%75.07%72.82%
Operating Margin
10.64%5.42%6.67%7.62%5.10%5.47%
Profit Margin
9.64%5.48%6.44%6.67%0.26%3.64%
Free Cash Flow Margin
-19.48%5.89%17.51%3.70%8.61%15.64%
EBITDA
59.739.9259.7776.1157.6957.99
EBITDA Margin
14.56%10.61%11.21%11.55%10.04%10.64%
D&A For EBITDA
16.0519.5524.2125.8928.428.19
EBIT
43.6520.3735.5650.2229.2929.8
EBIT Margin
10.64%5.42%6.67%7.62%5.10%5.47%
Effective Tax Rate
14.11%17.87%12.83%14.02%74.63%13.83%
Revenue as Reported
410376.17533.23659.2574.71544.73
Advertising Expenses
-59.4652.8563.859.4752.34
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.